Gilbert, Richard E.

Hypertension Canada’s 2020 Comprehensive Guidelines for the Prevention, Diagnosis, Risk Assessment, and Treatment of Hypertension in Adults and Children

Rabi, D. M., McBrien, K. A., Sapir-Pichhadze, R., Nakhla, M., Ahmed, S. B., Dumanski, S. M., Butalia, S., Leung, A. A., Harris, K. C., Cloutier, L., et al. (2020) · Canadian Journal of Cardiology

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 583

Effect of empagliflozin on erythropoietin levels, iron stores, and red blood cell morphology in patients with type 2 diabetes mellitus and coronary artery disease

Mazer, C. D., Hare, G. M. T., Connelly, P. W., Gilbert, R. E., Shehata, N., Quan, A., Teoh, H., Leiter, L. A., Zinman, B., Jüni, P., et al. (2020) · Circulation

Erythropoietin and Anemia TreatmentDiabetes Treatment and Management

Cited by 371

Are β-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials

Haas, S. J., Vos, T., Gilbert, R. E., & Krum, H. (2003) · American Heart Journal

Heart Failure Treatment and ManagementHeart rate and cardiovascular health

Cited by 194

Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials

Gilbert, R. E., & Thorpe, K. E. (2019) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementAcute Kidney Injury Research

Cited by 92